Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: December 6, 2021

DrugPatentWatch Database Preview

Details for Patent: 10,376,661

Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,376,661
Title:Opening element for opening an ampoule in an aerosol generation device and aerosol generation device comprising the opening element
Abstract: An opening element for opening an ampoule in an aerosol generation device includes a first member which has a conduit extending therethrough for guiding a fluid contained in the ampoule through the first member and a second member which is arranged at least partly inside or on the conduit. Further, an aerosol generation device includes such an opening element.
Inventor(s): Gallem; Thomas (Munich, DE), Hetzer; Uwe (Munich, DE), Pham; Stephen (San Diego, CA), Quintana; Reynaldo (Menlo Park, CA)
Assignee: PARI Pharma GmbH (Starnberg, DE)
Application Number:14/427,457
Patent Claim Types:
see list of patent claims
Delivery; Device;

Drugs Protected by US Patent 10,376,661

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,376,661

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
12184036Sep 12, 2012
PCT Information
PCT FiledSeptember 09, 2013PCT Application Number:PCT/EP2013/068592
PCT Publication Date:March 20, 2014PCT Publication Number: WO2014/040947

International Family Members for US Patent 10,376,661

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2883583 ⤷  Free Forever Trial
China 104619303 ⤷  Free Forever Trial
European Patent Office 2708219 ⤷  Free Forever Trial
European Patent Office 2895136 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.